Karyopharm Therapeutics Inc. - Common Stock (KPTI)

8.9000
+0.0500 (0.56%)
NASDAQ· Last Trade: May 15th, 1:44 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026